savient pharmaceuticals inc
(SVNT:NASDAQ GM)

Executive Profile*

Background*

Mr. Philip K. Yachmetz, JD has been Senior Vice President and Secretary of Savient Pharmaceuticals Inc. since November 2008 and as its General Counsel since May 28, 2004. Mr. Yachmetz served as an Executive Vice President and Chief Business Officer of Savient Pharmaceuticals Inc. from February 2006 to November 2008. He served as Senior Vice President of Corporate Strategy and Corporate Secretary at Savient Pharmaceuticals Inc. from May 28, 2004 to February 2006. He joined ... Savient from Progenics Pharmaceuticals Inc., where he served as General Counsel and Secretary from September 2000 to May 26, 2004 and Vice President from January 2002 to May 26, 2004. From 1998 to 2000, he served as Senior Vice President of Business Development, General Counsel and Secretary at StemCells, Inc.(formerly CytoTherapeutics Inc.). He served as Acting Chief Financial Officer and Treasurer of StemCells Inc. since April 2, 1999 and serves as its Senior Vice President. Mr. Yachmetz served as a Director of Legal & Corporate Affairs and Secretary of PlayNet Technologies Inc. from 1996 to 1997. From 1997 to 1998, he served as Principal and Managing Director of Millennium Venture Management LLC. From January 1989 to October 1996, he held positions at Hoffmann-La Roche Inc., as Senior Attorney and later as Senior Counsel for Savient Pharmaceuticals Inc. He is admitted to practice law in New York and New Jersey. Mr. Yachmetz received a BA in Political Science from George Washington University and a JD from California Western School of Law.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
SVNT:US	$0.74 USD	-0.0134

COMPETITOR COMPENSATION